News | August 02, 2024
Aster DM Healthcare posts Q1 FY25 PAT at Rs. 74 Cr
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
The academy has secured partnerships with 15 esteemed hospitals
The initiative aims to empower individuals to take proactive steps towards monitoring their health
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
The company plans to add 1700 beds by FY27 through the organic route
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Both the India and GCC entities will be operated by separate dedicated management teams
Subscribe To Our Newsletter & Stay Updated
